Skip to main content

Table 1 Demographic and baseline characteristics of patients between Ludangshen and placebo group

From: Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial

Characteristics

Ludangshen (n = 99)

Placebo (n = 98)

t/χ2/Z

P value

Male (n, %)

28 (28.3)

33 (33.7)

0.747

0.387

Age (n, %)

  

− 0.191

0.848

 ≤ 30

9 (9.1)

5 (5.1)

  

 31–40

16 (16.2)

23 (23.5)

  

 41–50

23 (23.2)

21 (21.4)

  

 51–60

25 (25.3)

18 (18.4)

  

 ≥ 61

26 (26.3)

31 (31.6)

  

BMI (Mean ± SD)

22.7 ± 2.86

23.7 ± 2.97

− 2.236

0.021

Smoking (n, %)

5 (5.0)

9 (9.2)

1.138

0.251

Drinking (n, %)

4 (4.0)

9 (9.2)

2.168

0.141

Temperature (Median, IQR)

36.5 (36.3–36.5)

36.5 (36.3–36.5)

− 0.048

0.962

SBP (Mean ± SD)

123.4 ± 11.2

124.2 ± 11.7

− 0.512

0.609

DBP (Median, IQR)

79 (73–81)

76 (70–80.25)

− 0.799

0.424

Breathing (Median, IQR)

18 (18–19)

18 (18–19)

− 0.434

0.664

Resting heart rate (Median, IQR)

80 (75–86)

79.5 (75–86)

− 0.498

0.625

Clinical classification (n, %)

  

− 0.296

0.767

 Mild cases

10 (10.1)

7 (7.1)

  

 Moderate cases

77 (77.8)

80 (81.6)

  

 Severe cases

11 (11.1)

11 (11.2)

  

 Critical cases

1 (1.0)

0 (0.0)

  

CT imaging (n, %)

  

0.359

0.549

 Normal

19 (19.2)

22 (22.5)

  

 Abnormal

80 (80.8)

76 (77.6)

  

Blood routine (n, %)

  

1.221

0.269

 Normal

99 (100.0)

94 (95.9)

  

 Abnormal

0 (0.0)

1 (1.0)

  

Allergy history (n, %)

16 (16.3)

14 (14.3)

0.133

0.737

Comorbidities (n, %)

25 (25.3)

27 (27.6)

0.166

0.683

Initial symptoms (n, %)

    

 Fatigue

94 (94.9)

90 (91.8)

 Anorexia

68 (68.7)

70 (71.4)

 Distention

43 (43.4)

34 (34.7)

 Loose stools

48 (48.5)

52 (53.1)

 Shortness of breath

50 (50.5)

50 (51.0)

Concomitant medication (n, %)

13 (13.1)

15 (15.3)

0.217

0.641

Hospitalization length (Median, IQR)

19 (11–28)

18 (10.75–26.5)

− 0.23

0.818

Discharge length (Median, IQR)

71 (59–81)

69.5 (50–80)

− 0.61

0.542

  1. BMI body mass index, SD standard derivation, IQR interquartile range, SBP systolic blood pressure, DBP diastolic blood pressure